Alterity Therapeutics Ltd (ATHE) — Financial Flexibility Index
Alterity Therapeutics Ltd (ATHE) has a Financial Flexibility Index of 0.00x as of June 2026. Free cash flow of $0.00 (operating CF $-12.80 Million minus capex $12.80 Million) represents 0% of total liabilities ($3.29 Million). Check Alterity Therapeutics Ltd cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Alterity Therapeutics Ltd Financial Flexibility Index (2002–2026)
Historical Financial Flexibility Index trend for Alterity Therapeutics Ltd across 25 annual periods. For the full cash flow conversion analysis, see Alterity Therapeutics Ltd cash conversion from operations.
Annual Financial Flexibility Index for Alterity Therapeutics Ltd (2002–2026)
Year-by-year free cash flow to debt coverage for Alterity Therapeutics Ltd. Explore debt repayment capacity of Alterity Therapeutics Ltd to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2026 | 0.00x | $0.00 | $-22.03 Million | $3.29 Million | ▲ +100.0% |
| 2025 | -3.16x | $-11.45 Million | $-11.45 Million | $3.62 Million | ▼ -36.1% |
| 2024 | -2.32x | $-12.60 Million | $-12.61 Million | $5.43 Million | ▲ +47.8% |
| 2023 | -4.45x | $-20.03 Million | $-20.04 Million | $4.50 Million | ▼ -114.0% |
| 2022 | -2.08x | $-12.25 Million | $-12.34 Million | $5.89 Million | ▲ +62.6% |
| 2021 | -5.56x | $-17.32 Million | $-17.33 Million | $3.12 Million | ▼ -62.8% |
| 2020 | -3.41x | $-9.41 Million | $-9.43 Million | $2.76 Million | ▲ +17.9% |
| 2019 | -4.16x | $-13.95 Million | $-13.95 Million | $3.36 Million | ▼ -77.8% |
| 2018 | -2.34x | $-6.18 Million | $-6.25 Million | $2.64 Million | ▲ +36.3% |
| 2017 | -3.67x | $-5.84 Million | $-5.87 Million | $1.59 Million | ▼ -16.6% |
| 2016 | -3.15x | $-7.42 Million | $-7.42 Million | $2.36 Million | ▲ +21.1% |
| 2015 | -3.98x | $-10.84 Million | $-10.87 Million | $2.72 Million | ▼ -14.5% |
| 2014 | -3.48x | $-13.77 Million | $-13.79 Million | $3.95 Million | ▼ -36.1% |
| 2013 | -2.56x | $-7.93 Million | $-7.95 Million | $3.10 Million | ▲ +35.5% |
| 2012 | -3.97x | $-6.82 Million | $-6.85 Million | $1.72 Million | ▼ -81.6% |
| 2011 | -2.19x | $-4.54 Million | $-4.56 Million | $2.08 Million | ▲ +26.7% |
| 2010 | -2.98x | $-4.69 Million | $-4.71 Million | $1.57 Million | ▲ +63.7% |
| 2009 | -8.21x | $-6.96 Million | $-6.99 Million | $847.43K | ▼ -61.0% |
| 2008 | -5.10x | $-9.36 Million | $-9.41 Million | $1.84 Million | ▼ -17.0% |
| 2007 | -4.36x | $-9.19 Million | $-9.20 Million | $2.11 Million | ▲ +36.4% |
| 2006 | -6.85x | $-11.60 Million | $-11.66 Million | $1.69 Million | ▼ -62.5% |
| 2005 | -4.22x | $-11.32 Million | $-11.37 Million | $2.68 Million | ▼ -119.5% |
| 2004 | -1.92x | $-5.18 Million | $-5.31 Million | $2.70 Million | ▲ +68.9% |
| 2003 | -6.19x | $-3.49 Million | $-3.58 Million | $564.54K | ▼ -53.3% |
| 2002 | -4.04x | $-3.68 Million | $-3.77 Million | $912.82K | — |